Parameter | HAL group | SAL-HAL group | SVL-HAL group | New-SVL control group | ANOVA P value | SVL-HAL vs. new-SVL P value |
---|---|---|---|---|---|---|
No. of participants | 51 | 50 | 41 | 48 | NA | NA |
Age (years) | 12.67 ± 1.16 | 12.10 ± 1.25 | 12.10 ± 1.22 | 11.98 ± 1.28 | 0.0025 | > 0.999a |
Sex (M/F) | 25/26 | 16/34 | 23/18 | 22/26 | 0.122 | NA |
Baseline SER (D) | −3.32 ± 1.11 | −3.35 ± 1.04 | −3.86 ± 0.88 | −3.73 ± 1.00 | 0.024 | > 0.999a |
Baseline AL (mm) | 25.10 ± 0.78 | 24.92 ± 0.79 | 25.38 ± 0.64 | 25.47 ± 0.80 | 0.001 | > 0.999a |
6-month AL elongation (mm) | 0.10 ± 0.08 | 0.10 ± 0.09 | 0.08 ± 0.09 | 0.16 ± 0.07 | < 0.001b | < 0.001a |
1-year AL elongation (mm) | 0.17 ± 0.12 | 0.18 ± 0.14 | 0.15 ± 0.14 | 0.28 ± 0.11 | < 0.001b | < 0.001a |